CRISPR Therapeutics overview after recent trading moves CRISPR Therapeutics (CRSP) has seen mixed trading recently, with the ...

Producing high levels of valuable medicinal compounds in plants has long been limited by the difficulty of precisely ...

Future AI-guided genomic analysis offers the potential to further optimize gene constructs, expression profiles, and performance traits, accelerating the development of next-generation materials.

Studies test whether gene-editing can fix high cholesterol. For now, take your medicine - Scientists are testing an entirely ...

Even in the best-case scenario, it’s incredibly disruptive. And this is where you’ve been quoted saying that A.I. will disrupt 50 percent of entry-level white-collar jobs. On a five-year time horizon, ...

Le porc génétiquement modifié ou « édité » ne pose aucun risque pour la santé, mais retenir l’information mine la confiance et l’hétérogénéité des choix pour les consommateurs.

In a significant breakthrough for cancer immunotherapy, collaborative studies published simultaneously in Immunity & ...

Accent Therapeutics launched a Phase I/II clinical trial last year to begin testing a small molecule inhibitor of KIF18A in ovarian cancers.

A scientific breakthrough not only promises faster testing for antimicrobial resistance, but also an ethical solution to the controversial issue of using rodents in research. University of Exeter ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the fourth quarter and ...

DENVER, Feb. 11, 2026 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market ...

Newly released records reveal the financier paid for genome sequencing and discussed gene editing research tied to longevity.